education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Advertisement
Advertisement
MIMS home
Drugs
Info
Lecitrol
Lecitrol
Manufacturer:
Interbat
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Description
Indications/Uses
Dosage/Direction for Use
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Description
Indications/Uses
Dosage/Direction for Use
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Polygonum cuspidatum
PE 50% resveratrol 50 mg, lecithin 95% (soybean) 300 mg
Indications/Uses
Helps maintain health.
Click to view Lecitrol detailed prescribing information
Dosage/Direction for Use
1 cap once daily.
Click to view Lecitrol detailed prescribing information
Administration
Should be taken with food.
Storage
View
Lecitrol storage
conditions for details to ensure optimal shelf-life.
Description
View
Lecitrol description
for details of the chemical structure and excipients (inactive components).
MIMS Class
Supplements & Adjuvant Therapy
/
Other Agents Affecting Metabolism
ATC Classification
A13A - TONICS ; Used as tonics.
Regulatory Classification
B
Presentation/Packing
Form
Lecitrol cap
Packing/Price
3 × 10's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk